A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK
Status:
Completed
Trial end date:
2021-12-03
Target enrollment:
Participant gender:
Summary
AB-106-C110 is China-only study, for investigating the drug interaction between AB-106 and
CYP3A4 inhibitor (Itraconazole)/CYP3A4 inducer (Rifampin)（n=56）